July 2003
Sun Mon Tue Wed Thu Fri Sat
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31    
Jun   Aug


For more search options, please see the Advanced search form and the section of the User's Guide, Tips for Searching PULSE.


C H A N N E L S
• PULSE Home Page
• EXECUTIVE EDITION

• US News
• Canada News
• UK News
• New Zealand News

• Consumer Advocacy
• Health Care Systems
• Managed Care/Medicaid
• Co-occurring Disorders
• Clinical studies
• Pharmaceutical News
• Criminal Justice Systems
• Legislative News


U S E R ' S   G U I D E
About PULSE
PULSE Channels
Archives
Adding comments
Using the # link
Items that require registration
PULSE syndication
Tips for Searching PULSE


E M A I L   S U B S C R I P T I O N S

For WEEKLY summaries of PULSE postings, see the weekly email subscription form.

For DAILY mailings (powered by Bloglet), please enter your e-mail address below:


P U B L I C A T I O N S

PULSE ANNUAL No. 2
January 2003

Recent Trends, Challenges and Issues in Funding Public Mental Health Services in the US
March 2002

PULSE ANNUAL No. 1
October 2001

 

PULSE is powered by
Radio Userland.

Listed on BlogShares

© Bill Davis, 2000-2003.

About PULSE | Channels | User's Guide | Email subscriptions | Publications




PULSE is a free service of the Centre for Community Change International, gathering new and noteworthy Internet resources for mental health providers, family members of individuals with mental illness, consumers of mental health services and consumer advocates. PULSE is researched, edited and designed by Bill Davis.



daily link  Tuesday, July 22, 2003


Genes for depression play role in mood disorders, shorter lifespan
Mental Health Weekly Digest story at the NAMI web site - "Researchers at the University of Pittsburgh have completed the first survey of the entire human genome for genes that affect the susceptibility of individuals to developing clinical depression."  
permalink  

Clinical Update in Bipolar Disorders: Second-Generation Antipsychotics in the Maintenance Therapy of Bipolar Disorder
A new CME unit from Medscape. [Viewing Medscape resources requires registration, which is free].  
permalink  

Aripiprazole Safe, Effective in Schizophrenia, Schizoaffective Disorder
Medscape Medical News Story - "Aripiprazole is safe and effective for the treatment of positive and negative symptoms in schizophrenia and schizoaffective disorder, according to the results of a four-week, double-blind trial published in the July issue of the Archives of General Psychiatry." [Viewing Medscape resources requires registration, which is free].  
permalink